NCCN

Prevalence of Financial Conflicts of Interest Among Guideline Authors Is Significant

Prevalence of Financial Conflicts of Interest Among Guideline Authors Is Significant

By

Collaboration between physicians and industry is vital in developing effective cancer treatments; however, a new study reveals the potential for undue influence among guideline authors may be significant.

Smoking cessation: Helping patients with cancer quit

Smoking cessation: Helping patients with cancer quit

By

The NCCN Clinical Practice Guidelines in Oncology for Smoking Cessation can help you plan a successful quit program for your patients who smoke.

Understanding the impact of disparities on cancer care

Understanding the impact of disparities on cancer care

By

Learn how patients' perceptions of health care can have a significant influence on the effectiveness of cancer care and patient education.

The role of sunitinib in the treatment of GIST

The role of sunitinib in the treatment of GIST

What is the role of sunitinib malate in the treatment of sarcomas?

Using anticoagulants to treat chemotherapy-related VTE

Using anticoagulants to treat chemotherapy-related VTE

Signs and symptoms of venous thromboembolism in oncology patients should be heeded with prompt therapeutic and mechanical interventions.

CT lung screening useful for some smokers, but drawbacks remain

Annual lung cancer screening with low-dose computed tomography may benefit some smokers, but uncertainty exists as to the harms of screening.

Psychosocial distress screening program can improve outcomes in cancer patients

By

A screening program put together by a multidisciplinary team was effective at measuring and reducing distress among cancer patients.

Distress: Assessing the effects of coping with cancer

Distress: Assessing the effects of coping with cancer

By

A cancer diagnosis can cause high levels of distress. Nurses should assess patients frequently and know how to intervene promptly.

Oxaliplatin improves survival in general colon cancer population

By

The survival advantage seen with the addition of oxaliplatin to adjuvant 5-FU was just as evident outside of randomized clinical trials as within.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs